The Food and Drug Administration algorithm. Special workshop—regulatory
The DOI matches its Crossref record.
Abstract
The Food and Drug Administration presently receives and evaluates over 40,000 case reports of adverse drug effects a year. Each report is objectively reviewed and evaluated. A causal association assessment between each drug and reaction is made. The objective causal assessments are based on four basic principles: (a) temporal eligibility, (b) dechallenge and outcome, (c) rechallenge and outcome, and (d) confounding factors. This presentation introduces the algorithm used by the FDA Division of Drug Experience and provides the basic information needed to use the FDA algorithm for making causal relationship assessments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current study assessed meditation causality according 11 of the 13 criteria that regulatory agencies use when making policy health decisions about possible adverse effects of medical procedures in instances where prospective trial and epidemiological data are not available [107–110].”
From The varieties of contemplative experience: A mixed-methods study of meditation-related challenges in Western Buddhists (2017) · cites this paper as [109]
In the citing paper
“In the current study, causal attribution to meditation was assessed according to the causality assessment criteria that regulatory agencies such as the World Health Organization (WHO), the Federal Drug Administration (FDA), and the National Institutes of Health (NIH) use to make health policy decisions [107–110].”
From The varieties of contemplative experience: A mixed-methods study of meditation-related challenges in Western Buddhists (2017) · cites this paper as [109]
Citations
Cites
Still being checked.
Cited by
Severe Adverse Cutaneous Reactions to Drugs
Roujeau, J. C., & Stern, R. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311906 · Cited by 1,571
Lindahl, J. R., Fisher, N. E., Cooper, D. J., Rosen, R. K., & Britton, W. B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176239 · Cited by 476
Methods for Causality Assessment of Adverse Drug Reactions: A Systematic Review
Agbabiaka, T. B., Savović, J., & Ernst, E. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00003 · Cited by 366
Defining and Measuring Meditation-Related Adverse Effects in Mindfulness-Based Programs
Britton, W. B., Lindahl, J. R., Cooper, D. J., Canby, N. K., & Palitsky, R. (2021) · Clinical Psychological Science · doi:10.1177/2167702621996340 · Cited by 278
Gallagher, R. M., Kirkham, J. J., Mason, J. R., Bird, K. A., Williamson, P. R., Nunn, A. J., Turner, M. A., Smyth, R. L., & Pirmohamed, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028096 · Cited by 218
Metadata
- Authors
- Turner, W. M.
- Affiliations
- United States Food and Drug Administration (US)
- Corresponding author
- Turner, Wayne M.
- Venue
- Drug Information Journal
- Published
- 1984-07
- Volume
- 18
- Issue
- 3-4
- Pages
- 259-266
- ISSN
- 0092-8615 (ISSN-L)
- OpenAlex
- W2029260658
- Cited by
- 37
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2017: 4 · 2015: 1 · 2014: 4 · 2012: 4
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Drug Information Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Keywords
- adverse drug reactions, adverse drug event reporting, confounding factors, drug safety regulation
- MeSH terms
- Humans, Product Surveillance, Postmarketing, United States, United States Food and Drug Administration, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Food and Drug Administration algorithm. Special workshop—regulatory. https://app.cochat.ai/papers/10.1177/009286158401800311
- The paper
- Turner, W. M. (1984). The Food and Drug Administration algorithm. Special workshop—regulatory. Drug Information Journal. https://doi.org/10.1177/009286158401800311
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.